COPD Respiratory Inhalers | Page 2

Respiratory Inhal Respiratory In At a Glance Respiratory Inhalers At a Glance At a Glance 2016 2016 s and offer scles in airway no lators raethlafxotrig3h-6t mhouurs i d o h c ne n o r e b br f t o s s s e i n t r n o 2016 all go g, wheezing and sh a a Xopenex t ® 2 e n ou b ch as coughi Ventolin g n i t ® c ® u s a s HFA m Proventil t o t r p ffer HFA Shcok relief of sym cles in airways and olevalbuterol relax tight musalbuterol HFA s r o ProAir® t tartrate qui a l i d r e f f o d L n o a o s n y sulfate g-acting beta -ag albuterol es in airwa sclh 3-6 hours muc ht n tigo laxr eb onist b 2 s of breath for ssulfate lantoirsstraRespiClick offer lasting relief of s dio og h hgouarsnd shortne ymptoms such n 3z-i6n ®c r o f o h t r a albuterol sulfate e r b b f t as coughin o ProAir s ess g, whee i n a t r n Xopenex o t h o s ® d 2 e g n a n b -aing inhalation Ventolin a Xopenex t wheezing as coughi ® ™ , 2 e g n i b h HFA g t Ventolin Arcapta u ® o ch powder nrgtm-sasuc ch as c HFA Proventil® HFA® oms su -achftsio Sereven Proventil® HFA Neohaler™ HFA sympt albuterol ympto f o ShcokrretlS levalbutero levalbuterol sulfate f e ief o i albuterolHFA rel Diskus® HFA ® albuterolindacaterol ProAir® tartrate qui ProAir tartrate quick sulfate inhalation powder salmeterol albuterol sulfate albuterol RespiClick inhalation p sulfate ® RespiClick albuterol sulfate sulfate ProAir ® inhalation albuterol sulfate HFA ProAir hey do not relieve sudden symptoms of coughing, wheezing powder inhalation of airway tissue; t albuterol ent swelling v e r p d n HFA a sulfate powder ® ds reduce oi icoster t r o c ed Alvesco Inhal albuterol sulfate mometasone furoate Flov 50 m 250 m 110 mcg, 220 mcg 100 mcg, 200 mcg HFA fluticasone en symptoms of coughing, wheezing or shortnessmometasone ddfuroate u s e v e i l e r t o n o d y e of breath h t ; 80 mcg, 160 mcg e u s furoate inhalation powder g of airway tis ellinciclesonide ®d prevent sw inhalation Aerospan ® reduce an ® steroid80smcg o c i t r o flunisolide ed c Alvesco HFA Inhal 100 mcg, 200 mcg ® Asmanex Flovent® Diskus powder 100 mcg, toms of n sym®pHFA Flovent e sudde Twisthaler® issue; the50y mcg, v e i l e r t o n o d yt wamcg r i 250 mcg a f o 44 mcg, 110 mcg, 220 m g n i l 110 mcg, 220 l e w s t n e v e r fluticasone p d fluticasone propionate mometasone reduce an propionate furoate Asmanex® ® mometasone furoate oids r e t s o Aerospan c corti d e l a Alvesco HFA Inh ® fluticasone furoate inhalation powder ciclesonide Asmanex inhalation HFA inhalation powder ® Arnuity® Ellipta 80 mcg flunisolide flutic propi inhala powd Asmanex® HFA Arnuity® Ellipta® 80 mcg, 160 mcg ® Asmanex Twisthaler® Asmanex® HFA Arnuity® Ellipta® All 100 mcg, 200 mcg osteroid an inhaled cortic ontain both furoate cfluticasone ® Twisthaler® powder mometasone furoate beta2-agonist (LABA) g n i t c a g n o l d tions inhalation powder® 80 mcg, 160 mcg medica Breo Ellipta® 110 mcg, 220 m mometasone ® Symbicort (HFA furoate Dulera® n ciclesonide 100/5, 200/5 inhalation budesonide 100/25 mcg, 200/25 mcg inatio mometasone furoate and b m powder Advair HFA and o fluticasone C formoterol fumaratecont nist (LABA)furoate 80 mcg ain both lonformoterol and long-acting beta -agoand steroid115/21, g-acting musc vilanterol rtico45/21, o c dihydrate d e l a h n i arinic h t flunisolide fumarate inhalation contain bo 230/21 s n o Symbicort (HFA) i Advair t a dihydrate Dulera c powder i Anoro Ellipta fluticasone ed Breo Ellipta 80/4.5, 160/4.5 Diskus 100/5, 200/5 umeclidinium propionate and tion m St a budesonide n 100/25 mcg,salmeterol 200/25 mcg i mometasone furoate and b 100/50, 250/50, and vilanterol m Advair HFA and o fluticasone furoate Re C formoterol fumarate inhalation xinafoate 500/50 Aerospan® 80/4.5, 160/4.5 ® 2 ® ® ® ® ® ® ® ® Advair Diskus® 45/21, 115/21, fluticasone 230/21 propionate fluticasone and salmeterol propionate and inhalation powder salmeterol xinafoate and vilanterol inhalation powder formoterol fumarate dihydrate dihydrate LABA) nd long-acting beta2-agonist ( corticosteroid a d e l a h n i h t o s relieve®cough, sputum production, whe contain b rgic) bronchodilator tions st (anticholine a c i d e Breo Ellipta tion m ranic antagonLoing-acting a n mcg, 200/25 mcg i b Incruse Ellipta a Advair HFA nchodilato100/25 s r fluticasone Com o r Muscting h45/21, b ) c i rg Seebri Neohaler and vilanterolfuroate oline115/21, 100/50, 250/50, 500/50 fluticasone propionate and salmeterol inhalation powder ® ® isShtor(ta-anc tic ™ ® ing 250/50, t-act100/50, Shor 500/50 fluticasone ® Atrovent HFA propionate ipratropium and salmeterol bromide inhalation powder glycopyrrolate ™ ® Seebri Neohalersalmeterol ipratropium glycopyrrolate bromide inhalation powder xinafoate 100/5, 200/5 ® mometasone furoate and Spiriva® HandiHaler ® cough, sputum production, wheezeformoterol relieveumeclidinium andtiotropium chest tighfumarate tbromide ness associated with inhalation powder dihydrate inhalation inhalation powder powder ® Spiriva HandiHaler® tiotropium bromide inhalation powder inhalation powder Dulera ® ® n 230/21 inhalation Advair antago Long-acting c i n fluticasone Incruse ® a powder ® r Ellipta® a c Diskus ® s u propionate and Atrovent HFA umeclidinium M tiot and powder Spiriva® Respimat® 1.25, 2.5 mcg tiotropium bromide = dose indicator = asthma = coPd S chronicR 1 ti b Tudorza™ Pressair™ aclidinium bro inhalation pow = BUiLt-in sPacer onchodilators relieve cough, sp r b ) c i g r e n i l o h sPacer ntic= BUiLt-in (=acoPd = dose indicator = asthma t s i n o g anta Long-acting c i n a r Incruse Ellipta Spiriva Hand a umeclidinium tiotropium bromide Musc reviewed by dennis Williams, Pharmd ® ng t-acti Shor Atrovent® HFA Seebri™ Neohaler® glycopyrrolate inhalation powder ® inhalation powder inhalation powder ipratropium bromide = dose indicator = asthma = coPd ® = BUiLt-in sPacer